Løndalen, Ayca
Blakkisrud, Johan
Revheim, Mona-Elisabeth
Dahle, Jostein
Kolstad, Arne
Stokke, Caroline
Funding for this research was provided by:
Nordic Nanovector ASA
University of Oslo
Article History
Received: 8 November 2021
Revised: 3 March 2022
Accepted: 4 April 2022
First Online: 29 April 2022
Declarations
:
: “All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.”
: Arne Kolstad was in part supported by grants from the Norwegian Cancer Society. Arne Kolstad is member of the Scientific Advisory Board of Nordic Nanovector ASA. Jostein Dahle is an employee and shareholder of Nordic Nanovector ASA. Ayca Løndalen has no conflict of interest. Johan Blakkisrud has received grants from South-Eastern Norway Regional Health Authority during the conduct of the study. Mona-Elisabeth Revheim has no conflict of interest. Caroline Stokke has no conflict of interest.